Kineta Nabs $600K NIH Grant

4/5/10

Kineta, the Seattle-based developer of treatments for autoimmune diseases, said it has received a two-year, $600,000 grant from the National Institutes of Health to do work that could enable clinical trials of a new drug for Type 1 diabetes, multiple sclerosis and other autoimmune diseases. Kineta said it plans to start clinical trials on the drug in the second half of 2010.

By posting a comment, you agree to our terms and conditions.